Thanks to an efficient health care industry, thus far Germany has been able to cope very well with the corona crisis. However, as the world’s pharmacy, Germany is losing ground. Its resilience to crises must be further increased and its competitiveness strengthened. Germany and Europe need targeted foreign health policy and a resolute industrial policy. Considering that globalisation will continue despite the coronavirus, compartmentalisation is not an option.